JDRF Adopts New Brand to Better Reflect its Mission for Type 1 Diabetes

JDRF Adopts New Brand to Better Reflect its Mission for Type 1 Diabetes

–New logo, tag line, and simpler name is an effort to clarify the organizations work for all people with type 1 diabetes and to increase understanding about the disease–

New York, NY, January 9, 2012 - JDRF – formerly known as the Juvenile Diabetes Research Foundation – recently launched a refreshed logo, new tag line, and a name that better reflects the state of type 1 diabetes (T1D) and the organization’s work, which remains committed to curing, treating, and preventing the disease.

The organization removed the word “juvenile” from its name for two reasons. One, the disease is now known as type 1 diabetes, or T1D, not juvenile diabetes. Two, T1D can strike at any age, and market research has shown that 85 percent of people in the United States with the disease are adults-some who were diagnosed as children, and others who were diagnosed later in life. By using only the acronym JDRF, the organization aims to better reflect its commitment toward all people with T1D.

JDRF’s refreshed logo not only removes the organization’s former name, but also incorporates a “T1D” symbol, shorthand for type 1 diabetes and an effort to distinguish the disease from type 2 diabetes. Unlike type 2 diabetes, T1D is an autoimmune disease with no known cause or cure, in which the body’s immune system attacks and destroys insulin-producing beta cells needed to turn food into energy for survival.

Since its founding in 1970, JDRF has been a leader in the fight to end T1D, through research funding and advocacy. Over the past 40 years, science began to reveal that putting an end to the disease, which affects as many as 3 million Americans, would require efforts geared not only toward curing, but also toward treating and preventing T1D and its complications. Each of these three areas of research are essential in eliminating T1D once and for all, and furthermore, researchers have found that knowledge into one area can provide invaluable information for another.

A constant and vital part of JDRF’s mission is improving the lives of people with T1D at all ages, and at all stages of the disease. While JDRF’s work remains the same, its new branding is a way to more accurately represent that work. A step forward for the organization and for people living with T1D, the transition strives to bring about more awareness about T1D and about the research progress being made for all people with the disease.

About T1D

In T1D, a person’s pancreas stops producing insulin, a hormone that enables people to get energy from food. People with T1D need to test their blood sugar and give themselves insulin (with injections or an insulin pump) multiple times every day, and carefully balance insulin doses with eating and daily activities throughout the day and night. However, insulin is not a cure for diabetes, and even with that intensive care, a significant portion of the day is still spent with either high or low blood sugar, placing people with T1D at risk for devastating complications such as heart attack, stroke, blindness, and amputation.

 

About JDRF

JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal.

Since its founding in 1970, JDRF has awarded more than $1.7 billion to diabetes research. Past JDRF efforts have helped to significantly advance the care of people with this disease, and have expanded the critical scientific understanding of T1D. JDRF will not rest until T1D is fully conquered. More than 80 percent of JDRF’s expenditures directly support research and research-related education.